# Proportion of Hysterectomy After Female Sterilization

> **NCT02532361** · — · COMPLETED · sponsor: **Bayer** · enrollment: 10578 (actual)

## Conditions studied

- Hysterectomy

## Interventions

- **DEVICE:** Hysteroscopic device placement including Essure (ESS305, BAY1454032)
- **PROCEDURE:** Tubal ligation

## Key facts

- **NCT ID:** NCT02532361
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 10578 (ACTUAL)
- **Last updated:** 2016-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02532361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02532361, "Proportion of Hysterectomy After Female Sterilization". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02532361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*